February 17, 2012 – For those of you who are worrying that there’s no cosmetic treatment for deep lines in the forehead and between the eyes, a new form of Botox has been FDA approved. Xeomin was given the green light by the FDA in July of 2011 and is starting to become available across the U.S.
Xeomin is just a pure form of Botox (botulinum toxin type A), according to a press release from the manufacturer, Merz Asethetics. It works the same way as traditional Botox injections; Xeomin blocks the muscle nerves from producing the chemical that causes the muscle to contract. Relaxed muscles don’t cause wrinkles, and Xeomin has shown good results in patients from about a week to a month after the initial injections. The wrinkle treatment lasts a minimum of three months, with results varying depending on the extent of the wrinkles and lines being treated.
Interestingly, because Xeomin has no additives it seems to cause fewer side effects related to immune response from the body. It also doesn’t have to be refrigerated. It does have potential side effects similar to those of Botox, so be sure to discuss those with your cosmetic surgeon before considering this treatment.
[tags]Xeomin, Botox, Wrinkle Treatment[/tags]